Innogen · News · January 17, 2014

Innogen Weekly News Roundup (11/01/14 - 17/01/14)

Innogen Weekly News Roundup (11/01/14 - 17/01/14)

All the latest news from around the world on the life sciences and emerging technologies.

A weekly roundup of global news on topics, including: agriculture, the bioeconomy, food and energy security, genes and genomics, global health and development, healthcare, innovation systems, pharma, synthetic biology, science and technology.


America Says No to GMO: Cheerios Go GMO-Free (The Daily Meal)

US ‘superweeds’ epidemic implicates GMOs (News24)

GM ban extension ‘hurting producers’ (The Advocate)

China says still no timetable on GMO commercialisation (Reuters)

America’s GM backlash should give Britain food for thought (Guardian)

Monsanto readies first-ever GMO wheat (RT)

Govt to pump €20 a year into rural knowledge drive


Top 10 Biofuels & Biobased Predictions for 2014 (Manufacturing.Net)

What’s Next for Biotech? (Barron’s)

The entrepreneurship of agribusiness (Nigerian Tribune)

Effective IP strategy a core business element (Scotsman)

UK report on life sciences calls for greater freedoms for EU member states (Pharma Letter)

Food & Energy Security

Will House Legislation on Contentious Biofuels Policy Ever Happen? (National Journal)

Genes & Genomics

Aiming to Push Genomics Forward in New Study (New York Times)

Global Development

Global Innovation through Science and Technology (SciDevNet)

Global Health

Sex Matters for Sleeping Sickness Microbes (Voice of America)

Angola: Sleeping Sickness Drops (All Africa)


Cubist Submits Clinical Trial Application to Initiate First-in-Human Study of CB-618—A Beta-Lactamase Inhibitor Discovered to Combat Antibiotic Resistance (Wall Street Journal)

How Much Do Medical Devices Cost? Doctors Have No Idea (Bloomberg Businessweek)

Researchers Fabricate Temporary Tattoo Biosensors (Forbes)

Innovation Systems

Linking research with innovation (The Engineer)


Clinical trial sectors feel beleaguered as regulators embark on snail-paced permits to conduct trials (PharmaBiz)

Big Data + Big Pharma = Big Money (Gant Daily)

Science & Technology

China cloning on an ‘industrial scale’ (BBC)

Synthetic Biology

Global Synthetic Biology Industry (Sacramento Bee)